stadapress potahovaná tableta 20mg 125mg - Resultados da pesquisa

teva israel ltd - atropine sulfate - תמיסה להזרקה - atropine sulfate 20 mg / 10 ml - atropine - atropine - relaxation of spastic situations of the gastrointestinal tract such as pylorospasm, relaxation of biliary and genitourinary tracts, reduction of salivation and bronchial secretion. atropine is used to combat cns and peripheral toxic effects and to suppress vagally-mediated bradyarrhythmias.

Israel - hebraico - Ministry of Health

אטרופין טבע 1 מגמל

teva israel ltd - atropine sulfate - תמיסה להזרקה - atropine sulfate 1 mg/ml - atropine - atropine - relaxation of spastic situations of the gastrointestinal tract such as pylorospasm, relaxation of biliary and genitourinary tracts, reduction of salivation and bronchial secretion. atropine is used to combat cns and peripheral toxic effects and to suppress vagally-mediated bradyarrhythmias.

Israel - hebraico - Ministry of Health

בינוקריט 1000 יחבל 0.5 מל

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

Israel - hebraico - Ministry of Health

בינוקריט 2000 יחבל 1 מל

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 2000 iu / 1 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob